Journals
Publish with us
Publishing partnerships
About us
Blog
Parkinson’s Disease
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Parkinson’s Disease
/
2011
/
Article
/
Tab 1
/
Research Article
Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients
Table 1
Biochemical, anthropometric, and clinical characteristics of the Parkinson disease (PD) patient population enrolled,
,
. Data are expressed as mean ± SD.
Parameter
Data (mean ± standard deviation)
Age (years)
62.4 ± 10.63
Duration of disease (years)
8.7 ± 6.1
Levodopa (mg)
532.7 ± 220.1
BMI (Kg/m
2
)
25.5 ± 4.2
Weight (Kg)
71.8 ± 15.7
Waist circumference (cm)
95.23 ± 15.8
Arm circumference (cm)
28.4 ± 3.97
Fat mass (%)
32.3 ± 7.74
Fat-free mass (%)
67.7 ± 6.7
Albumin (g/dL)
3.89 ± 0.2
Transferrin (mg/dL)
243.6 ± 40.5
Creatinine (mg/dL)
0.67 ± 0.1
ALT (U/L)
13.5 ± 6.6
AST (U/L)
16.8 ± 4.9
Triglycerides (mg/dL)
97.5 ± 46.3
Glucose (mg/dL)
87.5 ± 14.9
Total cholesterol (mg/dL)
189.0 ± 46.21
HDL cholesterol (mg/dL)
51.8 ± 16.4
Adiponectin (
μ
g/mL)
9.59 ± 5.97